FEDERATED HERMES, INC.

Position in CHRS — Coherus Oncology, Inc.

CIK 1056288 PITTSBURGH, PA

Position in CHRS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$6,822

+$204 QoQ

Shares Held

4,873

+24.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#123

of 145 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. CHRS ranks #134 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,822	4,873	+24.4%	Shares	Defined	2026-08-12
2026-03-31	$6,618	3,916	+101.9%	Shares	Defined	2026-05-11
2025-12-31	$2,754	1,940	+305.0%	Shares	Defined	2026-02-12
2025-09-30	$785	479	-17.7%	Shares	Defined	2025-11-03
2024-09-30	$605	582	-86.2%	Shares	Defined	2024-11-13
2022-09-30	$40,583	4,223	+55.0%	Shares	Defined	2022-11-14
2022-06-30	$19,729	2,725	-44.8%	Shares	Defined	2022-09-16
2022-03-31	$63,762	4,939	+16.7%	Shares	Defined	2022-05-13
2021-12-31	$67,526	4,231	-62.0%	Shares	Defined	2022-02-14
2021-09-30	$178,875	11,131	+6813.7%	Shares	Defined	2021-11-15
2021-03-31	$2,352	161	-99.7%	Shares	Defined	2021-05-13
2020-12-31	$870,146	50,066	+0.9%	Shares	Defined	2021-02-12
2020-09-30	$910,414	49,641	—	Shares	Defined	2020-11-12
No filing history on record for this holder in this stock.